Literature DB >> 24114768

Impact of frailty and functional status on outcomes in elderly patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: rationale and design of the IFFANIAM study.

Albert Ariza-Solé1, Francesc Formiga, Maria T Vidán, Héctor Bueno, Antoni Curós, Jaime Aboal, Cinta Llibre, Ferran Rueda, Eva Bernal, Angel Cequier.   

Abstract

The IFFANIAM study (Impact of frailty and functional status in elderly patients with ST segment elevation myocardial infarction undergoing primary angioplasty) is an observational multicenter registry to assess the impact of frailty and functional status on outcomes of elderly patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary angioplasty. STEMI patients age 75 years or older undergoing primary angioplasty will be extensively studied during admission in 4 tertiary care Hospitals in Spain, assessing their baseline functional status (Barthel index, Lawton-Brody index), frailty (Fried criteria, FRAIL scale [fatigue, resistance, ambulation, illnesses, and loss of weight]), comorbidities (Charlson index), nutritional status (Mini Nutritional Assessment-Short Form), and quality of life (Seattle Angina Questionnaire). Participants will be managed according current recommendations. The primary outcome will be the description of 1-year mortality, its causes, and associated factors. Secondary outcomes will be functional capacity and quality of life. Results will help to better understand the impact of frailty and functional ability on outcomes in elderly STEMI patients undergoing primary angioplasty, thus potentially contributing to improving their clinical management. Higher life expectancy has resulted in a large segment of elderly population and an increase in myocardial infarction in these patients. This calls attention to healthcare systems to focus on promoting methods to improve the clinical management of this population.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24114768      PMCID: PMC6649451          DOI: 10.1002/clc.22182

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  6 in total

1.  Barthel Index as a Predictor of 1-Year Mortality in Very Elderly Patients Who Underwent Percutaneous Coronary Intervention for Acute Coronary Syndrome: Better Activities of Daily Living, Longer Life.

Authors:  Satoshi Higuchi; Yusuke Kabeya; Kenichi Matsushita; Hiroki Taguchi; Haruhisa Ishiguro; Hideyasu Kohshoh; Hideaki Yoshino
Journal:  Clin Cardiol       Date:  2015-12-31       Impact factor: 2.882

2.  FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics.

Authors:  María T Vidán; Elísabet Sánchez; Francisco Fernández-Avilés; José A Serra-Rexach; Javier Ortiz; Héctor Bueno
Journal:  Clin Cardiol       Date:  2014-12-16       Impact factor: 2.882

3.  The relationship between frailty syndrome and quality of life in older patients following acute coronary syndrome.

Authors:  Izabella Uchmanowicz; Magdalena Lisiak; Marta Wleklik; Piotr Gurowiec; Marta Kałużna-Oleksy
Journal:  Clin Interv Aging       Date:  2019-05-07       Impact factor: 4.458

Review 4.  What do we know about frailty in the acute care setting? A scoping review.

Authors:  Olga Theou; Emma Squires; Kayla Mallery; Jacques S Lee; Sherri Fay; Judah Goldstein; Joshua J Armstrong; Kenneth Rockwood
Journal:  BMC Geriatr       Date:  2018-06-11       Impact factor: 3.921

5.  Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction.

Authors:  Carme Guerrero; Albert Ariza-Solé; Francesc Formiga; Manuel Martínez-Sellés; María T Vidán; Jaime Aboal
Journal:  J Geriatr Cardiol       Date:  2018-12       Impact factor: 3.327

Review 6.  Contemporary Revascularization Dilemmas in Older Adults.

Authors:  Sonali Kumar; Michael McDaniel; Habib Samady; Farshad Forouzandeh
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.